Ocular Therapeutix
OCUL
#5558
Rank
โ‚น137.27 B
Marketcap
โ‚น623.91
Share price
0.76%
Change (1 day)
-37.14%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -โ‚น27.74 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are โ‚น52.05 Million. In 2025 the company made an earning of -โ‚น24.92 Billion a decrease over its 2024 earnings that were of -โ‚น18.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น27.74 Billion11.31%
2025 -โ‚น24.92 Billion37.43%
2024 -โ‚น18.13 Billion139.68%
2023 -โ‚น7.57 Billion13.65%
2022 -โ‚น6.66 Billion984.05%
2021 -โ‚น0.62 Billion-95.79%
2020 -โ‚น14.58 Billion80.19%
2019 -โ‚น8.1 Billion44.01%
2018 -โ‚น5.62 Billion-5.38%
2017 -โ‚น5.94 Billion41.79%
2016 -โ‚น4.19 Billion12.47%
2015 -โ‚น3.73 Billion38.75%
2014 -โ‚น2.69 Billion115.12%
2013 -โ‚น1.25 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-โ‚น1.05 Billion-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-โ‚น0.48 Billion-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-โ‚น15.12 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
โ‚น16.57 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA